Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied
Estrel Congress Center Berlin,
20.05 - 23.05.2020
Präsident: Prof. Dr. med. Andreas Dietz
Schuler, PJ.;
Tews, D;
Brunner, C;
Laban, S;
Döscher, J;
Zinngrebe, J;
Wabitsch, M;
Debatin, Klaus-Michael;
Möller, P;
Hoffmann, TK.;
Fischer-Posovszky, P:
Cervical adipocytes and tumor cells interact in patients with head and neck cancer
Zech, Henrike Barbara;
Betz, CS;
Kriegs, M;
Köcher, S;
Mansour, W;
Möckelmann, N;
Böttcher, A;
Busch, Chia-Jung;
Petersen, C;
Rothkamm, K;
Rieckmann, T:
Ex-vivo slice cultures of tumor tissues confirm the DNA double-strand break repair defect of HPV-positive OPSCC and suggest a defect in the ATM-mediated DNA damage response
Affolter, A;
Rong, C;
Muller, MF.;
Xiang, F;
Jensen, A;
Weichert, W;
Major, G;
Plinkert, PK.;
Rotter, N;
Heß, J:
Adaptive ERK1/2 signalling as a response to HNSCC therapy
Bast, H;
Wilkat, M;
Drees, R;
Dünser, J;
Brhel, M;
Azoitei, N;
Marienfeld, R;
Frank, F;
Ushmorov, A;
Greve, J;
Goldberg-Bockhorn, E;
Theodoraki, Marie-Nicole;
Döscher, J;
Laban, S;
Schuler, P;
Hoffmann, TK.;
Brunner, C:
Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells
Brunner, C;
Mahr, A;
Bast, H;
Drees, R;
Dünser, J;
Azoitei, N;
Pscheid, R;
Greve, J;
Theodoraki, Marie-Nicole;
Döscher, J;
Laban, S;
Schuler, PJ.;
Hoffmann, TK.:
Hif-1α-dependent expression of Adenosine Receptor 2B (ADORA2B) promotes autonomous growth, EMT as well as CSC enrichment in cultures of cells derived from head and neck squamous cell carcinomas
Busch, Chia-Jung;
von der Heyde, E;
Welslau, M;
Hahn, D;
Bockmühl, U;
Langer, C;
Müller-Huesmann, H;
Gauler, T;
Waldenberger, D;
Dietz, A:
HANNA – Real-world data on effectiveness and safety of Nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Germany
Eyth, Christian Peter;
Hansen, S;
Bruderek, K;
Schirrmann, R;
Petra, A;
Wey, K;
Kollenda, S;
Hackel, A;
Vollmer, S;
Lang, S;
Epple, M;
Brandau, S:
Cetuximab-conjugated Nanoparticles as drug delivery systems. Distribution and biological effects on epithelial and mesenchymal cells in the head and neck area
Gostian, Antoniu - Oreste;
Hecht, M;
Eckstein, M;
Rutzner, S;
von der Grün, J;
Illmer, T;
Hautmann, M;
Brunner, T;
Laban, S;
Klautke, G;
Tamaskovics, B;
Frey, B;
Hartmann, A;
Rödel, C;
Budach, W;
Gaipl, U;
Fitkau, R;
Iro, H:
First-line treatment of locally advanced HNSCC with double checkpoint inhibition and radiotherapy based on CD8+ T cell infiltration.
Hess, J;
Feng, B;
Shen, Y;
Huang, Q;
Pastor Hostench, X;
Bieg, M;
Plath, M;
Huber, P;
Ishaque, N;
Eils, R;
Freier, K;
Weichert, W;
Zaoui, K:
Genetic and epigenetic landscape of the molecular immuno-signature in HNSCC
Kemper, M;
Olesch, Falk-Tony;
Schneider, M;
Lehnert, R;
Linge, A;
Haim, D;
Lauer, Günter;
Gudziol, V;
Löck, S;
Baumann, M;
Barreton, G;
Krause, M;
Zahnert, T:
Retrospective und prospective biomarker studies in early stage HNSCC- first clinical results-
Mytilineos, D;
Fürst, D;
Tsamadou, C;
Mytilineos, J;
Theodoraki, Marie-Nicole;
Döscher, J;
Schuler, P;
Brunner, C;
Hoffmann, T;
Laban, S:
HLA-Allele-frequencies differ between patiens with head neck cancer (HNSCC) and healthy controls and between HPV-positiv and HPV-negative HNSCC patients
Reichel, C;
Mittmann, L;
Schaubächer, J;
Hennel, R;
Zuchtriegel, G;
Canis, M;
Gires, O;
Krombach, F;
Holdt, L;
Brandau, S;
Vogl, T;
Lauber, K;
Uhl, B:
Excessive biological ageing of circulating neutrophils in HNSCC promotes tumor progression
Strüder, D;
Momper, T;
Irmscher, N;
Liese, J;
Schraven, S;
Zimpfer, A;
Junghanß, C;
Frerich, B;
Mlynski, R;
Maletzki, C:
Setup of a head and neck cancer biobank and patient-derived xenografts - Differential engraftment of surgical specimens and endoscopic biopsies
Weiland, T;
Tomazic, Peter Valentin;
Wolf, A;
Brcic, L;
Pondorfer-Schäfer, P;
Vasicek, S;
Holzmeister, C;
Kiss, P;
Graupp, M;
Thurnher, D:
DRH1 – Evaluating a blood-based marker for HPV16-induced tumors
Fehn, A;
Ezic, J;
Brunner, C;
Theodoraki, Marie-Nicole;
Döscher, J;
Schuler, P;
Greve, J;
Marienfeld, R;
Koretz, K;
Hoffmann, T;
Laban, S:
Abundance of immune checkpoint molecules and their ligands in Oropharyngeal Squamous cell carcinoma (OPSCC) depends on HPV status and can be modulated by demethylation.
Haider, Stefan Philipp;
Mahajan, A;
Zeevi, T;
Forghani, R;
Kann, B;
Judson, BL.;
Burtness, B;
Sharaf, K;
Reichel, C;
Baumeister, P;
Payabvash, S:
Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithms
Hoffmann, M;
Quabius, Elgar Susanne;
Brandt, P;
Heinrichs, A;
Kühnel, André;
Laudien, M;
Mlynski, R;
Hoppe, F;
Ambrosch, P:
HPV-DNA and -RNA in tonsils, sputum and tonsillar swabs of patients with tonsillar hyperplasia (H), chronic tonsillitis (CT) and tonsillar squamous cell carcinomas (TSCC)
Pondorfer-Schäfer, P;
Vasicek, Sarah Marvis;
Karakitsiou, M;
Weiland, T;
Graupp, M;
Wolf, A;
Strasser, A;
Moser, U;
Holzmeister, C;
Wild, D;
Brcic, L;
Thurnher, D:
C-reactive protein as prognostic marker in patients with p16-negative vs. p16-positive oropharyngeal squamous cell carcinoma